Olin OLN Aromatics and allylics — Sales
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Olin in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Olin’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Olin's aromatics and allylics — sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Olin's aromatics and allylics — sales?
- Olin (OLN) reported aromatics and allylics — sales of $144.5M in Q1 2026.
- How has Olin's aromatics and allylics — sales changed year-over-year?
- Olin's aromatics and allylics — sales increased by 2.5% year-over-year, from $141M to $144.5M.
- What is the long-term trend for Olin's aromatics and allylics — sales?
- Over 4 years (2021 to 2025), Olin's aromatics and allylics — sales has grown at a -21.0% compound annual growth rate (CAGR), from $1.45B to $564.7M.
- What does aromatics and allylics — sales mean?
- This metric represents the total gross revenue generated from the sale of aromatics and allylic chemical products within a specific reporting period. It reflects the market demand and pricing power for these specialized chemical intermediates used in various industrial applications. Tracking this revenue stream helps investors assess the segment's contribution to the overall business and its sensitivity to broader chemical market cycles.